Campion Asset Management »

Regeneron Pharmaceuticals shares owned by Campion Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Campion Asset Management from 13F filings

Historical chart of Campion Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Campion Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Campion Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $220k 250 878.29
2023-09-30 $206k 250 822.96
2023-03-31 $205k 250 821.67

More positions owned by Campion Asset Management

Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Rus Mid Cap Etf (IWR)
Lockheed Martin Corporation (LMT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Real Estate Etf (VNQ)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Expnd Tec Sc Etf (IGM)
Vanguard World Fds Comm Srvc Etf (VOX)
Microsoft Corporation (MSFT)

View all positions for Campion Asset Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals